Sneek Peak: Rick Stewart on Cytisinicline redefining the future of nicotine dependence

https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/b7/c0/31/b7c031b7-44b4-c652-ffc5-1af6a1969e50/mza_3591023405865880209.jpg/600x600bb.jpg

Innovating Tomorrow's Medicine

Jeff Trickett

15 episodes

1 week ago

Dr. Jeff Trickett is a neuroscientist, biotech strategist, and author. He hosts Innovating Tomorrow’s Medicine, a podcast highlighting the people and ideas reshaping the future of healthcare. He created the show to go beyond the headlines with honest conversations from biotech founders, researchers, clinicians and investors who are turning bold ideas into real-world impact. His goal is to discover the strategies they use, the insights behind their success and breakthroughs that will define the future of medicine; while challenging the way we think about health, science, and progress.

Life Sciences

Science

RSS

All content for Innovating Tomorrow's Medicine is the property of Jeff Trickett and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Life Sciences

Science

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_episode/44169658/44169658-1763248363621-9409fb1ee11f2.jpg

Sneek Peak: Rick Stewart on Cytisinicline redefining the future of nicotine dependence

Innovating Tomorrow's Medicine

1 minute 57 seconds

1 month ago

Sneek Peak: Rick Stewart on Cytisinicline redefining the future of nicotine dependence

Sneak Peek: Innovating Tomorrow’s Medicine ft. Rick Stweart.In this exclusive preview, Rick shares a glimpse into Achieve Life Sciences and Cytisinicline which is redefining the future of nicotine dependence.➡️ Full episode launches on 4 December 🔔 Subscribe and hit the bell so you don’t miss it!🎙️ About the Show:Innovating Tomorrow’s Medicine features bold conversations with pioneers shaping the future of healthcare, biotechnology, and life sciences.📌 Stay tuned for the full interview where we explore and share unique insights:– FDA acceptance for its cytisinicline New Drug Application (NDA)– Commercial Readiness– Financial strategy and capital efficiency– Market impact and public health–Engagement and investor relations – Personal reflections and futureoutlook#SneakPeek#Rick Stewart#FutureOfMedicine